BUPRENORPHINE/NALOXONE ARROW 8 mg/2 mg, comprimé sublingual sécable — plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 7 comprimé(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930160480 -
CIP7
3016048 -
CIS
67154226
What the source publishes
- Holder
- ARROW GENERIQUES
- Active ingredients
- CHLORHYDRATE DE BUPRÉNORPHINE, BUPRÉNORPHINE, NALOXONE, CHLORHYDRATE DE NALOXONE DIHYDRATÉ
- Form
- comprimé sécable
- Package
- plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 7 comprimé(s)
- Routes
- sublinguale
- Administrative status
- cancelled
- Supply regime
- prescription limitée à 4 semaines ; délivrance fractionnée de 7 jours ; liste I ; prescription en toutes lettres sur ordonnance sécurisée
- Marketing status
- Déclaration d'arrêt de commercialisation
- Authorised on
- 2018-09-26
- Prescription
- Prescription or restricted
Names this record is found by
- BUPRENORPHINE/NALOXONE ARROW 8 mg/2 mg, comprimé sublingual sécable — plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 7 comprimé(s)
- BUPRENORPHINE/NALOXONE ARROW 8 mg/2 mg, comprimé sublingual sécable
- CHLORHYDRATE DE BUPRÉNORPHINE
- BUPRÉNORPHINE
- NALOXONE
- CHLORHYDRATE DE NALOXONE DIHYDRATÉ
Complete source data
{
"cis": "67154226",
"cip7": "3016048",
"form": "comprimé sécable",
"name": "BUPRENORPHINE/NALOXONE ARROW 8 mg/2 mg, comprimé sublingual sécable — plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 7 comprimé(s)",
"cip13": "3400930160480",
"holder": "ARROW GENERIQUES",
"routes": [
"sublinguale"
],
"holders": [
"ARROW GENERIQUES"
],
"currency": "EUR",
"marketed": false,
"bdmStatus": "Warning disponibilité",
"useDomain": "unknown",
"publicPrice": "5.69",
"authorisedOn": "2018-09-26",
"compositions": [
{
"name": "CHLORHYDRATE DE BUPRÉNORPHINE",
"nature": "SA",
"strength": null,
"linkageNumber": "1",
"substanceCode": "21888",
"dosageReference": null,
"pharmaceuticalElement": "comprimé"
},
{
"name": "BUPRÉNORPHINE",
"nature": "FT",
"strength": "8 mg",
"linkageNumber": "1",
"substanceCode": "54459",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
},
{
"name": "NALOXONE",
"nature": "FT",
"strength": "2 mg",
"linkageNumber": "2",
"substanceCode": "65807",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
},
{
"name": "CHLORHYDRATE DE NALOXONE DIHYDRATÉ",
"nature": "SA",
"strength": null,
"linkageNumber": "2",
"substanceCode": "79853",
"dosageReference": null,
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "prescription limitée à 4 semaines ; délivrance fractionnée de 7 jours ; liste I ; prescription en toutes lettres sur ordonnance sécurisée",
"dispensingFee": "1.02",
"medicinePrice": "4.67",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "BUPRENORPHINE/NALOXONE ARROW 8 mg/2 mg, comprimé sublingual sécable",
"marketingStatus": "Déclaration d'arrêt de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "non",
"packageDescription": "plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 7 comprimé(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65%"
],
"marketingDeclaredOn": "2023-01-18",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "cancelled",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"CHLORHYDRATE DE BUPRÉNORPHINE",
"BUPRÉNORPHINE",
"NALOXONE",
"CHLORHYDRATE DE NALOXONE DIHYDRATÉ"
],
"authorisationProcedure": "Procédure décentralisée",
"prescriptionConditions": [
"prescription limitée à 4 semaines",
"délivrance fractionnée de 7 jours",
"liste I",
"prescription en toutes lettres sur ordonnance sécurisée"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation abrogée",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930160480"